Serological diagnosis of Chagas' disease: A potential confirmatory assay using preserved protein antigens of Trypanosoma cruzi

被引:17
|
作者
Mendes, RP
HoshinoShimizu, S
DaSilva, AMM
Mota, I
Heredia, RAG
Luquetti, AO
Leser, PG
机构
[1] UNIV FED SAO PAULO,ADOLFO INST,SAO PAULO,BRAZIL
[2] UNIV FED SAO PAULO,BUTANTAN INST,SAO PAULO,BRAZIL
[3] FED UNIV GOIAS,GOIANIA,GO,BRAZIL
关键词
D O I
10.1128/JCM.35.7.1829-1834.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The diagnosis of Chagas' disease relies mostly on data provided by immunologic tests, but inconclusive results often require elucidation, especially in blood banks, When six different types of Trypanosoma cruzi epimastigote antigens were studied by an immunoblotting assay (IBA), a preserved protein antigen (Ag PP) was found to present the most interesting immunochemical features because of its high reactivity with anti-T. cruzi antibodies, Thus, the IBA with Ag PP (PP IBA) was assessed with panels of coded and noncoded serum samples prepared in different laboratories, including the Brazilian Reference Laboratory for Chagas' Disease, It was found that serum samples from patients proved (clinically, eletrocardiographically, serologically, and epidemiologically) to have Chagas' disease consistently recognized 12 bands (140, 100, 85, 78, 59, 57, 46, 35, 27, 23, 20, and 18 kDa) of Ag PP, In contrast, sera from nonchagasic patients, including patients with mucocutaneous leishmaniasis, were negative or reacted weakly, and one serum sample did not have more than five different bands. These bands were 78, 57, 46, 35, 27, 23, 20, or 18 kDa, A criterion was adopted to interpret the results obtained in the PP IBA, The criterion considered positive a serum sample recognizing all 12 bands and considered negative a serum sample that did not recognize any of the bands except the eight nonspecific hands mentioned above, The PP IBA indicated maximum sensitivity and specificity as well as high positive and negative predictive values, The data demonstrate that the PP IBA discriminates chagasic from nonchagasic infections and seems to be applicable as a confirmatory assay for elucidating inconclusive results obtained by standard serology.
引用
下载
收藏
页码:1829 / 1834
页数:6
相关论文
共 50 条
  • [31] A novel Trypanosoma cruzi secreted antigen as a potential biomarker of Chagas disease
    Nagarkatti, Rana
    Acosta, David
    Acharyya, Nirmallya
    de Araujo, Fernanda Fortes
    Eloi-Santos, Silvana Maria
    Martins-Filho, Olindo Assis
    Teixeira-Carvalho, Andrea
    Debrabant, Alain
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [32] Immunodiagnosis of Chagas disease: Synthesis of three latex-protein complexes containing different antigens of Trypanosoma cruzi
    Gonzalez, Veronica D. G.
    Garcia, Valeria S.
    Vega, Jorge R.
    Marcipar, Ivan S.
    Meira, Gregorio R.
    Gugliotta, Luis M.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 77 (01) : 12 - 17
  • [33] In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease
    Bellotti, G
    Bocchi, EA
    deMoraes, AV
    Higuchi, MD
    BarberoMarcial, M
    Sosa, E
    EstevesFilho, A
    Kalil, R
    Weiss, R
    Jatene, A
    Pileggi, F
    AMERICAN HEART JOURNAL, 1996, 131 (02) : 301 - 307
  • [34] An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens
    Umezawa, ES
    Bastos, SF
    Coura, JR
    Levin, MJ
    Gonzalez, A
    Rangel-Aldao, R
    Zingales, B
    Luquetti, AO
    da Silveira, JF
    TRANSFUSION, 2003, 43 (01) : 91 - 97
  • [35] TRYPANOSOMA-CRUZI CIRCULATING ANTIGENS IN PATIENTS WITH CHAGAS-DISEASE IN AN ENDEMIC AREA
    ALONSO, JM
    PIVIDORI, S
    GUILLERON, C
    MEDICINA-BUENOS AIRES, 1986, 46 (01) : 69 - 72
  • [36] CHAGAS-DISEASE - POLYSPECIFICITY OF ANTIBODIES AGAINST TRYPANOSOMA-CRUZI ACIDIC ANTIGENS
    ORDONEZ, P
    GEA, S
    IOSA, D
    VOTTEROCIMA, E
    ACTA TROPICA, 1995, 59 (02) : 93 - 103
  • [37] Evaluation of flavones as inhibitors of Trypanosoma cruzi transialidase as a potential treatment for Chagas disease flavones as inhibitors of Trypanosoma cruzi transialidase
    Niguela-Narvaez, Dayanna, V
    Guachichullca-Espinoza, Karina, V
    Luzuriaga-Blandin, Maria N.
    Bueno-Leon, Hernan P.
    Arias-Becerra, Jimmy A.
    Torres-Segarra, Silvia M.
    INVESTIGACION CLINICA, 2022, 63 : 92 - 104
  • [38] Multi-epitope proteins for improved serological detection of Trypanosoma cruzi infection and Chagas Disease
    Duthie, Malcolm S.
    Guderian, Jeffery A.
    Vallur, Aarthy C.
    Misquith, Ayesha
    Liang, Hong
    Mohamath, Raodoh
    Luquetti, Alejandro O.
    Carter, Darrick
    Tavares, Suelene N. B.
    Reed, Steven G.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 84 (03) : 191 - 196
  • [39] An immunoblot assay using recombinant antigens to confirm antibodies to Trypanosoma cruzi
    Shah, D. O.
    Chang, C.
    Cheng, K.
    Salbilla, V.
    Haller, A.
    Adya, N.
    Leiby, D. A.
    Kirchhoff, L.
    Schochetman, G.
    Marchlewicz, B.
    TRANSFUSION, 2007, 47 (03) : 207A - 207A
  • [40] PURIFIED TRYPANOSOMA-CRUZI SPECIFIC GLYCOPROTEIN FOR DISCRIMINATIVE SEROLOGICAL DIAGNOSIS OF SOUTH-AMERICAN TRYPANOSOMIASIS (CHAGAS-DISEASE)
    GUHL, F
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1990, 85 (04): : 531 - 532